Montefiore St. Luke's Cornwall

What it reported doing in 2024

Montefiore St. Luke's Cornwall (MSLC) is a two-Campus 242-bed acute care hospital located in Newburgh, NY, with a robust Ambulatory Center in Cornwall, NY, and satellite locations in Newburgh, New Windsor, and Fishkill, NY. For 150 years, MSLC has been a cornerstone of high-quality healthcare, fostering a healing environment through community collaboration, dedicated staff, and a rich history. The Newburgh campus is inclusive of an Emergency Department, Level III Trauma Center, Intensive Care Unit, Birthing Center, Neonatal Intensive Care Unit and much more. This campus also includes the Kaplan Family Center for Cardiovascular Medicine and Interventional Radiology, which encompasses three state-of-the-art Cardiac Catheterization Rooms. In addition, MSLC offers expansive surgical services such as Metabolic and Bariatric Surgery, Robotic Surgery, Thoracic Surgery, and advanced surgical technologies used in the treatment of urologic disorders. The Cornwall Campus is a multifaceted outpatient center that includes a comprehensive Imaging Center, the Medical Group at MSLC offering both Primary and Specialty care, outpatient laboratory services, rehabilitative medicine, vascular services, dialysis, pain management, and wound care. The campus also includes the Littman Cancer Center, which offers the latest technology in radiation therapy with its newly installed Radixact system, which precisely treats cancer. This new advanced equipment not only provides cutting-edge radiation therapy but also reduces the number of necessary radiation treatments for patients undergoing cancer care. Additionally, the Infusion suite on the Cornwall campus provides everything from antibiotic treatments to chemotherapy. MSLC is dedicated to meeting the evolving healthcare needs of our region. In 2024, expanded its outpatient services to improve access to care. * MSLC's Internal Medicine Residency program continues to thrive. MSLC is incredibly proud of its Graduate Medical Education Program, originally established to help to shape the future of medicine in Hudson Valley. The program offers both inpatient and outpatient settings. * Additionally, MSLC launched a Comprehensive Weight Loss Center, offering both medical and bariatric surgical treatment options, to address the growing obesity epidemic, and to aid those struggling with their weight loss. * Both Colorectal Surgery and Endocrinology were added to the growing list of services within the Medical Group at MSLC. * The organizations Bloodless Medicine & Patient Blood Management (PBM) program expanded, including the establishment of an Anemia Center-the first of its kind in Orange County-designed to optimize health and reduce or eliminate the need for transfusions. In 2024, MSLC expanded our urological surgical services, now offering Blue Light Cystoscopy, an innovative tool for detecting bladder cancer. This summer, we introduced Radixact Radiation Therapy, which allows us to treat prostate and other cancers with fewer sessions and less impact on surrounding healthy tissue. This year, MSLC also became the first hospital in New York State to offer a cutting-edge AI-Powered platform for Aquablation Therapy, a groundbreaking treatment for men with benign prostatic hyperplasia (BPH). These technological advancements reflect our dedication to bringing world-class medicine to our community. Providing exceptional care is at the core of what MSLC is privilege to offer the community. This commitment is recognized by many outside organizations and includes: * Magnet Designation by the American Nursing Credentialing Center (ANCC), * Certification as a Level III Trauma Center by the American College of Surgeons Committee on Trauma * American Heart Association/American Stroke Association's Get With the Guidelines-Stroke Gold Plus Quality Achievement Award for the 17th consecutive year. * American Heart Association's Mission: Lifeline STEMI Receiving Center Silver recognition * Accredited by the American College of

Financial Efficiency

• Mission deployment rate: 86.7%; rating input score 87
• Program expense ratio: 87.1%; rating input score 87
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 92.9%; rating input score 93; 17th percentile among comparable filings
• Pay-setting controls: 6 of 6 controls in place; rating input score 100
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Pass
  • Written employment contract: Pass
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Limited
• Grant itemization coverage: 99.2%; rating input score 99; 38th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 88.9%; rating input score 89; 36th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 0.4%; rating input score 34; 34th percentile among comparable filings
• Total-asset coverage ratio: 0.63; rating input score 24; 24th percentile among comparable filings
• Liabilities to assets ratio: 0.45; rating input score 40; 40th percentile among comparable filings
• Officer compensation ratio: 1.9%; rating input score 57; 57th percentile among comparable filings

Growth

• Program expense growth: 4.3% per year; rating input score 100; 34th percentile among comparable filings
• Revenue growth: 3.8% per year; rating input score 100; 30th percentile among comparable filings
• Asset growth: 0.7% per year; rating input score 100; 9th percentile among comparable filings